Wellness Initiative for 2008 Tour de Georgia Presented by AT&T Led by New Partnership With Blue Cross and Blue Shield ...(n. The officialbeneficiary is the Aflac ...),Health
Navigation Links
Wellness Initiative for 2008 Tour de Georgia Presented by AT&T Led by New Partnership With Blue Cross and Blue Shield of Georgia
Date:3/13/2008
n. The official beneficiary is the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta. The event is sanctioned by the Union Cycliste Internationale (2.HC ranking), and is part of the USA Cycling Professional Tour, making the event one of the top stage races for elite athletes around the world. The Tour de Georgia is owned and operated by the Tour de Georgia Foundation (501 c3) and managed by Medalist Sports (http://www.medalistsports.com). Route maps, host venue information, merchandise offerings and sponsor news is available at the official website, http://www.tourdegeorgia.com.
ABOUT THE AFLAC CANCER CENTER AND BLOOD DISORDERS SERVICE OF CHILDREN'S
The Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta is a national leader among childhood cancer, hematology, and blood and marrow transplant programs, serving infants to young adults. Recognized as one of the top five pediatric cancer centers in the country by Child magazine, the Aflac Cancer Center treats more than 325 new cancer patients each year and follows more than 2,000 patients with sickle cell disease, hemophilia and other blood disorders. The Aflac Cancer Center is one of many programs at Children's committed to enhancing the lives of children through excellence in patient care, research and education. Children's, one of the top three pediatric healthcare systems in the country, is a not-for-profit organization that benefits from the generous philanthropic and volunteer support of our community. Visit http://www.aflaccancercenter.org or call 404-250-KIDS for more information.
'/>"/>
| SOURCE Blue Cross and Blue Shield of Georgia Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Finicky Felines Award Four Stars to New Wellness(R) Healthy Indulgence Everyday Entrees
2. CIGNA Employees Take to the Road to Promote Health and Wellness
3. Concentra Acquires Assets of Renew Health & Wellness
4. Why Are Most Health & Wellness Products Doomed to Failure?
5. ASTRO, Wellness Community South Bay Cities Join to Promote Cancer Survivorship
6. Hooper Holmes Names Chris Behling President of Health & Wellness Division
7. Blue Cross Blue Shield of Michigan Offers New Approach to Customer Group Wellness
8. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
9. Shop n Save Pharmacy Helps Vitalize Members of Wellness-based Health Insurance Plan
10. LiveHealthier Announces Its Health and Wellness Coaching Solution for Employer Groups is Now Compatible With Microsoft HealthVault
11. Physicians Wellness Network Announces Lab Testing Services for Consumers built on Microsoft HealthVault
Post Your Comments:
(Date:9/5/2008)...5 /PRNewswire-USNewswire/ -- As the general electi...Federation of Independent,Business ( http://www.nf...ates for a greater focus on the healthcare concern...epublican conventions are over, NFIB,is asking bot...tacles faced,by small businesses as they further d...
(Date:9/5/2008)...r risk prediction models are enhanced by taking in...NA repair capacity, according to research teams le... D. Anderson Cancer Center in two complementary pa...revention Research . , In the first study to foc...results based on increased exposure to certain ris...
(Date:9/4/2008)...a case-control study, the presence of measles viru...nd GI disturbances than in children with only GI d...nset were unrelated to MMR vaccine timing. Study ...y of Science on September 4 ( http://dx.plos.org/...mplementation of measles vaccines in 1963, three t...
(Date:9/4/2008)... Medelis, an oncology contract research organiz...nical Trials: A Nuanced Approach to Get Into the C...arry, a preclinical research scientist with 35 yea...al studies are commonly viewed as straightforward ...operate without true integration with preclinical,...
Breaking Medicine News(10 mins):Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3[0] Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns[0] Creating lung cancer risk models for specific populations refines prediction[0] Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism[0] Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development
...vered a potential new target, Akt2/PKB, a fat meta...er, PGC-1a for the treatment of type 2 diabetes. ...led by Morris J. Birnbaum at the University of Pen...icine. When a person eats, insulin is secreted by...
... to reel under a scorching June sun with most area...s Friday and Sri Ganganagar in Rajasthan at a sear... clouds were nowhere in sight. Following close b...as Amritsar in Punjab with a maximum of 46 degrees...
... conduct psychological tests on its recruits in a ...atricides that have occurred in the past few years...new tests (being introduced from October), we woul...f a recruit, his ability to grasp a given situatio...
...pitals Friday said that its recently launched Ches... and save lives of cardiac patients. The hospita...t week to address the need of preventing the loss ...e lives. Anil Maini, president, corporate develop...
Other Medicine News:Health News:Army to Conduct Psychological Tests During Recruits to Curb Suicides 2(Date:9/4/2008)...TaqMan(R) real-time PCR testing for the diagnostic..., Calif., Sept. 4 /- The U.S. Food & ...OBAS(R) TaqMan(R) HBV Test,the first assay for qu....S.,The test uses Roche,s real-time PCR technology...n a patient,s blood. Doctors may use viral load,te...
(Date:9/4/2008)...Enroll 750 Women at More Than 100 Sites in the U.S...Rx Pharmaceuticals, a,privately-held biopharmaceut...ization of compounds to treat endocrine, metabolic...t it has initiated a second,Phase 3 clinical trial...,estrogen-free oral therapy in development for the...
(Date:9/4/2008)...atient Identification for Targeted Therapies ...ment HUNTINGTON BEACH, Calif., and AMSTERDAM, N...ld leader in molecular cancer diagnostics,today a...ostic test that,allows physicians to quantitativel...ogen receptor (ER), progesterone receptor (PR) and...
(Date:9/3/2008).... 3 /- Simcere,Pharmaceutic... supplier of,branded generic pharmaceuticals and m...oduct Endu (also known as Endostar) in China,anno...l study., At the request of the SFDA, Simcere ini...te the safety and therapeutic efficacy of Endu, a ...
Breaking Medicine Technology:FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3China Clean Energy Updates Business Outlook 6279 1China Clean Energy Updates Business Outlook 6279 2China Clean Energy Updates Business Outlook 6279 3New York Resident Elected President of Lions Clubs International 22871 1New York Resident Elected President of Lions Clubs International 22871 2Medical Machines Online Announces the Overstock and Release of a New ECG Machine 22868 1Medical Machines Online Announces the Overstock and Release of a New ECG Machine 22868 2Urgent Care Provider NextCare Introduces CareForToday Medical Insurance Plan 22865 1Urgent Care Provider NextCare Introduces CareForToday Medical Insurance Plan 22865 2[0] FDA Approves First Hepatitis B Viral Load Test[0] QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome[0] Agendia Launches TargetPrint(R) for Breast Cancer Patients[0] Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
...June 1, 2007-Cytos Biotechnology AG is delighted t...ations of its novel,immunotherapeutic CYT003-QbG10...inical results for CYT003-QbG10 were obtained,and ...I Congress of,the European Academy of Allergology ... June 9-13, 2007 in Göteborg,Sweden. The EAA...
... Final Analysis of the Results, ISTA Plans to Init...E, Calif., May 31, 2007 /PRNewswire-FirstCall/ -- ...ive results from the,preliminary analysis of the C..., which is being developed as a treatment for dry ...achieved a strong,trend in the objective sign of b...
Other Medicine Technology:CYT003-QbG10 to treat allergy to be presented at the Congress of,the European Academy of Allergology and Clinical Immunology,(EAACI), June 9-13, 2007 2ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 2ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 3ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 4ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 57 mm blade, angled right. Flat handle.
1 mm diameter. Angled 33 degrees. Round handle.
3.5 mm blade. Round handle. Designated most popular model or size.
7 mm curved blade. Round handle.
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |